🟢 GT Biopharma is trading 5% up with no confirmed company-specific catalyst

GT Biopharma is trading at $7.02, up +5.02%, with no confirmed company-specific news explaining the move.

• At 11:16 a.m. ET October 12, 2026, the official press-release page listed September 15 as the latest release.
• The Nasdaq and S&P 500 were slightly lower. An October 9 filing covered up to 13.5 million shares offered by existing holders; the company was not selling shares and would receive no proceeds. The filing does not establish a reason for Monday’s rise.